This stock has never had its fda approval rerate. Its so cheap, especially to a big pharma who are always on the look out for new profit streams. A lot of posters going on that its needs to prove itself via sales? Why would a rival sit idle and let it steal their market share?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
-0.005(3.23%) |
Mkt cap ! $303.9M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 15.5¢ | 15.0¢ | $85.79K | 556.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 41 | 2000077 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 1809870 | 41 |
View Market Depth
| Last trade - 09.59am 21/07/2025 (20 minute delay) ? |
| BOT (ASX) Chart |